Clinical trials: Enhanced External Counterpulsation (EECP)
Enhanced External Counterpulsation (EECP), Cardiac Output
Impact of Enhanced External Counterpulsation (EECP) on Cardiac Force Index
Regular exercise can prevent cardiovascular disease, but there is also a risk of sudden cardiac death. Exercise-related sudden death often occurs unconsciously and there is no relevant monitoring mechanism.
- Conditions
- Enhanced External Counterpulsation (EECP), Cardiac Output, Cardiac Force Index
- Trial name
- NCT05080023
- Testing
- Enhanced External Counterpulsation (EECP)
- Where
- 5 sites in Taiwan
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Chi-Ming Chu
Coronary Artery Disease, Congestive Heart Failure
Enhanced External Counterpulsation
Enhanced external counterpulsation (EECP) is a noninvasive circulatory assist device that has been as a treatment option for refractory angina in left ventricular (LV) dysfunction.
- Trial name
- NCT01355315
- Volunteers
- 19 people
- Sponsor
- Far Eastern Memorial Hospital
Long COVID Symptoms
Using Enhanced External Counterpulsation to Recover Cardiovascular Function for Patient of Chronic Diseases
The goal of this clinical trial is to learn whether enhanced external counterpulsation (EECP) therapy can improve cardiopulmonary function and symptoms in adults with long COVID.
- Trial name
- NCT07492953
- Testing
- enhanced external counterpulsation
- Where
- Taiwan
- Volunteers
- 10 people
- Sponsor
- National Defense Medical Center, Taiwan